{"as_of":"2026-08-22T16:42:00Z","caps":{"database_statements":6,"inbound":100,"outbound":100},"context_digest":"sha256:4e2eeeb6e88eb14b7358c887865a78c51f7d74cb9e3dfd7d18a9f86c0708fe9a","coverage":[{"denominator":23,"lane":"reference_resolution","note":"Typed states for the displayed outbound observations.","records_observed":23,"source":"paper_references, paper_reference_links","source_observed_at":"2026-08-10T22:18:29.623977Z","state":"measured"},{"denominator":23,"lane":"standing_notices","note":"One-hop event checks from named stored sources.","records_observed":23,"source":"scholarly_work_events, retraction_status_cache","source_observed_at":"2026-08-22T06:32:14.747728+00:00","state":"measured"},{"denominator":0,"lane":"inbound_itemization","note":"Pith citing papers itemized under the disclosed page cap.","records_observed":0,"source":"paper_references, paper_reference_links","source_observed_at":null,"state":"measured"},{"denominator":1,"lane":"external_citation_measurements","note":"A source-named dated measurement, never combined with another source.","records_observed":0,"source":"cited_works","source_observed_at":null,"state":"measured"}],"external_citation_measurements":[],"inbound":[],"links":{"evidence":"/evidence","html":"/paper/2501.04724/citation-record","integrity":"/paper/2501.04724/integrity","json":"/paper/2501.04724/citation-record.json","paper":"/paper/2501.04724"},"outbound":[{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.1111/nep.13742","metadata_source":"doi_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:30.533102Z","title":null,"venue":null,"work_id":"19cc65c1-762f-416e-8607-de38d4bf6e8e","year":2020},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":1,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.113696Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:80685170063ce95c4c783c232a4534c20a95b8dad453c440fde68b8ae8a14027","observation_id":"ccbba746-197a-4cb9-95b6-505215b14b4d","resolution":{"observed_at":"2026-08-10T22:18:30.617096Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-22T06:32:14.747728+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:31.642313Z","title":null,"venue":null,"work_id":"bb3b5b1f-b86a-456c-bac9-546ab6041945","year":2022},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":2,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.211230Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:511eb975e106225fa3e6f534cb1fb0b439c98476c972128dbbe7701b0dc78ea4","observation_id":"37219e8b-10e9-4756-851e-ec468239aa62","resolution":{"observed_at":"2026-08-10T22:18:31.686409Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-22T06:32:14.747728+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.1245/s10434-015-4739-1","metadata_source":"doi_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:30.379238Z","title":"De La Cruz, A","venue":null,"work_id":"e1a91540-1798-4bf8-8ecb-b0d1710154ce","year":2015},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":3,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.271382Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:4be362386b3b0553eda4c8a420ccfdba18df1c55c79751a27624d535bfba6f76","observation_id":"d809fc9a-4358-4bcd-b109-c40897fd66bb","resolution":{"observed_at":"2026-08-10T22:18:30.510579Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-22T06:32:14.747728+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:29.277493Z","title":null,"venue":null,"work_id":null,"year":2006},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":4,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.277493Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:1346b05b820db64843fccce397b1d794f1f2ffa23636c406a964af885c117521","observation_id":"2b171b73-a631-428f-87d4-e812aeb28610","resolution":{"observed_at":"2026-08-10T22:18:29.277493Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.1186/2193-1801-2-222","metadata_source":"doi_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:30.244940Z","title":"Dong and C","venue":null,"work_id":"b74c94ca-5777-4260-9d5c-384b3d4e823d","year":2013},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":5,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.283226Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:4f5be8f498c57a103d8d46664e5a2d068604967d4e9d7f79b8820d4eede862cb","observation_id":"5b1a3794-f94a-4dc9-b118-337e2d8b2755","resolution":{"observed_at":"2026-08-10T22:18:30.340726Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-22T06:32:14.747728+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.1164/rccm.202010-3943st","metadata_source":"doi_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:31.518933Z","title":null,"venue":null,"work_id":"7a345729-aa1c-4853-8c5c-83e84149bb08","year":2021},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":6,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.289715Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:585427448e88737be8fe6c165cbaab6df6ede1947bb050e5ddd86df298e1d176","observation_id":"237969d0-46a4-4f6c-9f36-292e58850dff","resolution":{"observed_at":"2026-08-10T22:18:31.629393Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-22T06:32:14.747728+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.1093/eurheartj/ehab745","metadata_source":"doi_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:30.227000Z","title":null,"venue":null,"work_id":"41d24134-02c9-412d-93af-c473e731875b","year":2021},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":7,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.295211Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:f197a12eef798ff58d2594722f5c7845e732f6b7d655408d8af5eb04dc282c89","observation_id":"3fc1362c-a364-436e-aa99-5e742fad1848","resolution":{"observed_at":"2026-08-10T22:18:30.233833Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-22T06:32:14.747728+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:29.300657Z","title":"An intro- duction of variable and feature selection","venue":null,"work_id":null,"year":2003},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":8,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.300657Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:50f7e49a695c8c72366dd4c0d890b6746175b07da090282731ac74d729effa47","observation_id":"6a4e75bd-e280-433d-979d-7798845fdfd4","resolution":{"observed_at":"2026-08-10T22:18:29.300657Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.1038/s41572-019-0111-2","metadata_source":"doi_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:30.008938Z","title":"Harbeck, F","venue":null,"work_id":"dde02192-dab8-44e6-a87e-a7c98b31913e","year":2019},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":9,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.360813Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:5e3a1c69225f77b69653d36a92e1b867b664951de0e95b9b4a625904aa78daf7","observation_id":"56c85ff7-b58b-44b2-ba73-ded57b0b4bf4","resolution":{"observed_at":"2026-08-10T22:18:30.089549Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-22T06:32:14.747728+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:31.384524Z","title":null,"venue":null,"work_id":"abcb0298-33cc-409d-9b49-ff2de90ec1d0","year":null},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":10,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.433512Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:5d6dec521bb7adbf0cd7160c21e51726d9e93059a9f9778db0a5171c75215309","observation_id":"a67e6176-7cba-41f4-a976-b65ae292c5b3","resolution":{"observed_at":"2026-08-10T22:18:31.390237Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-22T06:32:14.747728+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.3390/healthcare10122395","metadata_source":"doi_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:29.826735Z","title":null,"venue":null,"work_id":"75043ab9-62aa-47b6-a53b-6f4ed36c01cd","year":2022},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":11,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.445993Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:6efdb2bef69397430c48908be3afa8027fa040db743428af77b016cfae04561e","observation_id":"e6572802-08e9-44f2-b078-580746b9df61","resolution":{"observed_at":"2026-08-10T22:18:29.880087Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-22T06:32:14.747728+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:29.451399Z","title":"Msaouel, J","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":12,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.451399Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:c8187a48103e4936faf10642279c898d002b02f8f9b629ad3efc59a5d1d6c2d0","observation_id":"b6a3eeec-6456-49f3-b3fc-e4d862cd7eec","resolution":{"observed_at":"2026-08-10T22:18:29.451399Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:31.218058Z","title":"Olier, Y","venue":null,"work_id":"109cd12f-4c11-4359-b576-63cc3c715811","year":null},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":13,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.457080Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:f9d0f78e76cc27e2a316de853bc9488ae4085d044fbdc6ebfe0c9e62f07139ba","observation_id":"80c76c78-e2cb-4cc7-bd36-4fe2177daddf","resolution":{"observed_at":"2026-08-10T22:18:31.295834Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-22T06:32:14.747728+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:31.202035Z","title":null,"venue":null,"work_id":"e9b5cc4b-52f9-4dd7-84b6-9290c1c5649d","year":2018},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":14,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.481505Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:062d6a72c13b0020aa5cdb860a3009a2effbe8ce675d6ada578d061aa0a914a9","observation_id":"e3220707-da55-43dd-a81b-e36f24b27201","resolution":{"observed_at":"2026-08-10T22:18:31.207601Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-22T06:32:14.747728+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:31.042130Z","title":null,"venue":null,"work_id":"ba182c76-b22f-4e98-96f8-1e2f016a7d77","year":2002},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":15,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.540168Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:9378fd70e5922ee90d3e391821f90661a57718d9acb46ba6005a4e7e67340592","observation_id":"71b2b4d5-3294-49e8-a131-b044b882ed08","resolution":{"observed_at":"2026-08-10T22:18:31.121300Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-22T06:32:14.747728+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":"2022.86488","doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:30.743182Z","title":"Shi and B","venue":null,"work_id":"4610de0d-1456-4d2a-aa34-0d427ddd723d","year":2022},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":16,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.605108Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:57da6e665e4abaf1f507372e0479ee26a2e977768637bf2d1612d73d60630a6a","observation_id":"5797dbe1-033a-4b70-a028-0cf5fe182e66","resolution":{"observed_at":"2026-08-10T22:18:30.822544Z","resolver_source":"raw_fallback","status":"metadata_mismatch"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-22T06:32:14.747728+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:31.024328Z","title":"Shimizu, P","venue":null,"work_id":"f40ded47-bfc2-4cff-b77c-5c1666b7cc53","year":2003},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":17,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.609840Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:f73628d86d4f404c3da85386e06429cd9f19297b28f96e13c5b36fc82cf771e2","observation_id":"3899b21c-0383-4254-8b53-cb2611844a81","resolution":{"observed_at":"2026-08-10T22:18:31.030460Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-22T06:32:14.747728+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:30.948213Z","title":"Di- rectlingam: A direct method for learning a linear non- gaussian structural equation model","venue":null,"work_id":"0e003232-db23-4f3b-9929-5dcfa73020ad","year":2011},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":18,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.614423Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:a54e25c59efde709d7d7b68b2b6abb9ba25cd9940aa8f7fceeab2fb1c424a2e6","observation_id":"69ff5a3f-69a7-4852-96a9-313c87df8b04","resolution":{"observed_at":"2026-08-10T22:18:31.011555Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-22T06:32:14.747728+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:30.833572Z","title":"Spirtes, C","venue":null,"work_id":"a18589c3-88e2-4796-91fa-b928a3e33f16","year":2001},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":19,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.619553Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:d386e2affbf2ed89aa867ec49f522b718c008415c45a163b70068b1f48803cee","observation_id":"b8678fe7-e9e9-49d7-a997-042a0f0fc875","resolution":{"observed_at":"2026-08-10T22:18:30.840392Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-22T06:32:14.747728+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.1007/s12094-024-03459-8","metadata_source":"openalex","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-20T11:03:42.707129Z","title":null,"venue":"Clinical & Translational Oncology","work_id":"d956eb6a-ff7f-414a-a1f8-a491bc5f1eef","year":2024},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":20,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.623977Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:87c9e0a002f9e4e47054f0540ee2fa56add5a143a30244cebf3d0fce0d42f6ca","observation_id":"f618adb4-9785-4c7b-b2d9-3020cf496d08","resolution":{"observed_at":"2026-08-10T22:18:29.789283Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-22T06:32:14.747728+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.1007/978-1-4757-3462-1","metadata_source":"openalex","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-12T11:03:20.376878Z","title":null,"venue":"Springer series in statistics","work_id":"17a8ebef-62a2-47fb-8e0d-5db7d6f1489f","year":null},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":2001,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.440234Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:58e696ac207af80ea55887ab64b56f37531e51bf9f77cf79b2fc6a7a45913942","observation_id":"396f3ea9-b26f-4aee-9a47-e6f5981342db","resolution":{"observed_at":"2026-08-10T22:18:29.997251Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-22T06:32:14.747728+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.1186/s12874-023-02058-5","metadata_source":"doi_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:29.800929Z","title":null,"venue":null,"work_id":"8e22c8d8-d638-4265-ae2f-459abde4c93a","year":null},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":2023,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.462232Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:02155b984c2b4e64d67400e88fe8cac5aa054ac9bcb4c0fa21d72e7fcbecdf1c","observation_id":"51fe6bda-36b8-4de1-b816-51057c15cc77","resolution":{"observed_at":"2026-08-10T22:18:29.805624Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-22T06:32:14.747728+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-10T22:18:29.265836Z","title":"PMID: 38572751","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients","version":1},"reference_index":2024,"source":"pdf_text","source_observed_at":"2026-08-10T22:18:29.265836Z"},"links":{"citing_paper":"/paper/2501.04724"},"observation_digest":"sha256:36586faa5ea72d919683eff3075136bbace383f3d9423e991e9ce503851943b1","observation_id":"23360837-6b3b-4713-bb50-6251fc8779e1","resolution":{"observed_at":"2026-08-10T22:18:29.265836Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}}],"paper":{"arxiv_id":"2501.04724","last_updated":"2025-01-04T00:17:12Z","latest_version":1,"primary_category":"stat.AP","snapshot_observed_at":"2026-08-10T22:12:07.571914Z","submitted_at":"2025-01-04T00:17:12Z","title":"Guiding Treatment Strategies: The Role of Adjuvant Anti-Her2 Neu Therapy and Skin/Nipple Involvement in Local Recurrence-Free Survival in Breast Cancer Patients"},"reference_resolution":{"displayed":23,"state_counts":{"malformed_identifier":0,"metadata_mismatch":1,"parse_uncertain":0,"unresolved":8,"verified_exact":10,"verified_fuzzy":4},"total_outbound_references":23},"refusal":"A citation records a reference. It does not transfer a finding from one paper to another.","schema":"pith.paper-citation-record.v1","standing_sources":[{"observed_at":"2026-08-22T06:32:14.747728+00:00","source":"crossref"},{"observed_at":"2026-08-22T06:32:06.552537+00:00","source":"retraction_watch"}],"thesis":"As of 22 August 2026, this Paper Citation Record lists 23 of 23 outbound references and 0 inbound Pith citation observations for arXiv:2501.04724."}